Notes
![]() ![]() Notes - notes.io |
7%, 11% and 4.8% for the ≥70-year group (p=0.530). Median OS time, and 1,2,3-year OS rates were 14months, 54.1%, 23.4%, 13.9% for the 65-69-year old group, and 12months, 49.3%, 21.5%, 10% for the ≥70-year group (p=0.357). No differences were recorded in relation to different groups of age.
The PSM analyses showed a similar outcome in 65-69-year old patients compared to older ones notwithstanding a more burdensome RT schedule. Hypofractionated RT treatment has to be considered also in this group of younger elderly, newly-diagnosed GBM patients.
The PSM analyses showed a similar outcome in 65-69-year old patients compared to older ones notwithstanding a more burdensome RT schedule. Hypofractionated RT treatment has to be considered also in this group of younger elderly, newly-diagnosed GBM patients.Idiopathic pulmonary fibrosis (IPF) is a progressive, fibrotic lung disease with an unknown cause. Uncertainties still remain regarding the pathogenesis of IPF, and the prognosis of this disease is poor despite some recent improvements in treatment. Radiation induced lung injury (RILI) is a common complication and a dose-limiting toxicity of thoracic radiotherapy. Importantly, IPF is a crucial risk factor for pulmonary toxicity after thoracic radiotherapy. Although IPF is not universally accepted as a definite contraindication for thoracic radiotherapy at present, it has been shown that IPF can increase the risk of severe and fatal complications after thoracic radiotherapy. Proton beam therapy has shown promising results in reducing the incidence of thoracic radiotherapy related life-threatening complications in IPF patients, but the current evidence is not sufficient to recommend the standard use of it. Many similarities are noticeable between IPF and RILI in terms of pathogenesis and underlying mechanisms. Better understanding of the mechanisms of IPF and RILI may enable clinicians to provide safer and more effective thoracic radiotherapy treatments in cancer patients with IPF. In this review, we summarize the current knowledge of IPF, present the importance of IPF in radiation oncology practice, and highlight the similarities and relationship between IPF and RILI.
Stereotactic radiotherapy (SRT) should be applied with a biologically effective dose with an α/β of 12 (BED
)≥40Gy to reach a 1-year local control (LC)≥70%. The aims of this retrospective study were to report a series of 81 unresected large brain metastases treated with Linac-based multifraction SRT according to the ICRU 91 and to identify predictive factors associated with LC.
Included in this study were the first 81 brain metastases (BM) consecutively treated with Linac-based volumetric modulated arc therapy (VMAT) multifraction SRT from 2017 to 2019. The prescribed dose was 33Gy for the GTV and 23.1Gy (70% isodose line) for the PTV in 3 fractions (3f). Mean BM largest diameter and GTV were 25.1mm and 7.2cc respectively. Mean follow-up was 10.2months.
LC was 79.7% and 69.7% at 1 and 2years respectively. Significant predictive factors of LC were GTV D
(HR=0.84, CI 95%=0.75-0.95, p=0.004) and adenocarcinoma as the histological type (HR=0.29, CI 95%=0.09-0.96, p=0.042) in univariate and multivariate analysis. A threshold of 29Gy for GTV D
was significantly correlated to LC (1-year LC=91.9% for GTV D
≥29Gy vs 69.6% for GTV D
<29Gy (p=0.030)), corresponding to a BED
=52.4Gy. No tumor progression was observed for a BED
≥53.4Gy, corresponding to a GTV D
≥20Gy /1f and GTV D
≥29.4Gy 3f. Median OS was 15months. Symptomatic radionecrosis occurred in 4.9% of cases.
The GTV D
is a strong reproducible significant predictive factor of LC for brain SRT. Dose prescription should lead to a GTV BED
≥52.4-53.4Gy to significantly improve LC, corresponding to respectively a GTV D
≥19.7-20Gy/1f and 29-29.4Gy/3f.
The GTV D98% is a strong reproducible significant predictive factor of LC for brain SRT. Dose prescription should lead to a GTV BED12 98% ≥ 52.4-53.4 Gy to significantly improve LC, corresponding to respectively a GTV D98% ≥ 19.7-20 Gy/1f and 29-29.4 Gy/3f.
A significant number of reported COVID-19 cases can be traced back to superspreader events (SSEs), where a disproportionally large number of secondary cases relative to the standard reproductive rate, R0, are initiated. CL-14377 inhibitor Although a superspreader is an individual who undergoes more viral shedding and transmission than others, it appears likely that environmental factors have a substantial role in SSEs. We categorise SSEs into two distinct groups 'societal' and 'isolated' SSEs.
We summarise SSEs that have occurred using multiple databases that have been cross referenced to ensure numbers are as reliable as we can ascertain. This enables more focussed and productive control of the current pandemic and future pandemics, especially as countries and regions ease lockdown restrictions.
'Societal' SSEs pose a significant threat as members of the event are free to mingle and can infect individuals in the outside community. On the other hand, 'isolated' SSEs can be effectively quarantined as only a few individuals can transmit the virus from the isolated community to the outside community, therefore lowering further societal infection.
'Societal' SSEs pose a significant threat as members of the event are free to mingle and can infect individuals in the outside community. On the other hand, 'isolated' SSEs can be effectively quarantined as only a few individuals can transmit the virus from the isolated community to the outside community, therefore lowering further societal infection.
To develop clinically relevant interpretive standards for the Spinal Cord Injury - Functional Index/Capacity (SCI-FI/C) Basic Mobility and Self-Care item bank scores.
Modified "bookmarking" standard-setting methodology, including 2 stakeholder consensus meetings with individuals with spinal cord injury (SCI) and SCI clinicians, respectively, and a final, combined (consumers and clinicians) "convergence" meeting.
Two SCI Model System centers in the United States.
Fourteen adults who work with individuals with traumatic SCI and 14 clinicians who work with individuals with SCI.
Placement of bookmarks between vignettes based on SCI-FI Basic Mobility and Self-Care T scores. Bookmarks were placed between vignettes representing "No Problems," "Mild Problems," "Moderate Problems," and "Severe Problems" for each item bank.
Each consensus group resulted in a single set of scoring cut points for the SCI-FI/C Basic Mobility and Self-Care item banks. The cut points were similar but not identical between the consumer and clinician groups, necessitating a final convergence meeting.
Homepage: https://www.selleckchem.com/products/Abitrexate.html
![]() |
Notes is a web-based application for online taking notes. You can take your notes and share with others people. If you like taking long notes, notes.io is designed for you. To date, over 8,000,000,000+ notes created and continuing...
With notes.io;
- * You can take a note from anywhere and any device with internet connection.
- * You can share the notes in social platforms (YouTube, Facebook, Twitter, instagram etc.).
- * You can quickly share your contents without website, blog and e-mail.
- * You don't need to create any Account to share a note. As you wish you can use quick, easy and best shortened notes with sms, websites, e-mail, or messaging services (WhatsApp, iMessage, Telegram, Signal).
- * Notes.io has fabulous infrastructure design for a short link and allows you to share the note as an easy and understandable link.
Fast: Notes.io is built for speed and performance. You can take a notes quickly and browse your archive.
Easy: Notes.io doesn’t require installation. Just write and share note!
Short: Notes.io’s url just 8 character. You’ll get shorten link of your note when you want to share. (Ex: notes.io/q )
Free: Notes.io works for 14 years and has been free since the day it was started.
You immediately create your first note and start sharing with the ones you wish. If you want to contact us, you can use the following communication channels;
Email: [email protected]
Twitter: http://twitter.com/notesio
Instagram: http://instagram.com/notes.io
Facebook: http://facebook.com/notesio
Regards;
Notes.io Team